President Trump's escalating trade threats, including potential tariffs on digital services and pharmaceutical pricing, are meeting a more resolute stance from Europe, which views these actions as infringements on its sovereignty. EU officials are opting for slower, technical processes to manage disputes.
Europe's resistance to President Trump's escalating trade demands signals a potential shift in transatlantic trade relations, as the EU prioritizes its sovereignty and employs a more deliberate strategy to manage disputes, potentially leading to prolonged trade tensions.
President Trump's administration has implemented a 10 percent tariff on certain European Union goods, with further threats of investigations into Europe's digital restrictions and pharmaceutical pricing practices. These potential actions could breach the Turnberry agreement, which limits U.S. duties on most EU imports to 15 percent. The Office of the U.S. Trade Representative confirmed an investigation into digital restrictions is expected soon, and a separate review of Germany's drug pricing is ongoing.
European officials view these trade actions as an infringement on their sovereignty, particularly concerning taxation, healthcare, and competition policy. Jeromin Zettelmeyer, head of the think tank Bruegel, noted that Trump's political standing has weakened, potentially influencing negotiations. However, the EU is adopting a strategy of engaging through slower, technical processes rather than public confrontations, which play into Trump's negotiating style. German Chancellor Friedrich Merz is reportedly not rushing to make concessions on drug pricing, with Berlin anticipating the U.S. trade investigation to last at least a year.